VOYA Investment Management
PCVX icon

VOYA Investment Management’s Vaxcyte PCVX Stock Holding History

VOYA Investment Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.78M Buy
65,110
+3,547
+6% +$193K ﹤0.01% 982
2026
Q1 		$3.58M Buy
61,563
+13,808
+29% +$750K ﹤0.01% 966
2025
Q4 		$2.2M Buy
47,755
+13,964
+41% +$625K ﹤0.01% 1182
2025
Q3 		$1.22M Sell
33,791
-10,505
-24% -$348K ﹤0.01% 1422
2025
Q2 		$1.44M Sell
44,296
-262,433
-86% -$8.6M ﹤0.01% 1420
2025
Q1 		$11.6M Buy
306,729
+5,169
+2% +$413K 0.01% 693
2024
Q4 		$24.7M Sell
301,560
-2,319
-0.8% -$230K 0.03% 476
2024
Q3 		$34.7M Buy
303,879
+15,873
+6% +$1.43M 0.04% 407
2024
Q2 		$21.7M Buy
288,006
+98,338
+52% +$6.69M 0.02% 521
2024
Q1 		$13M Buy
189,668
+5,791
+3% +$401K 0.01% 667
2023
Q4 		$11.5M Buy
183,877
+1,384
+0.8% +$71.9K 0.01% 696
2023
Q3 		$9.3M Buy
182,493
+20,240
+12% +$999K 0.01% 721
2023
Q2 		$8.1M Buy
162,253
+119,464
+279% +$5.66M 0.01% 803
2023
Q1 		$1.6M Hold
42,789
– – ﹤0.01% 1440
2022
Q4 		$2.05M Buy
42,789
+22,172
+108% +$870K ﹤0.01% 1317
2022
Q3 		$495K Buy
20,617
+858
+4% +$21.8K ﹤0.01% 2031
2022
Q2 		$430K Buy
19,759
+3,738
+23% +$86.5K ﹤0.01% 1925
2022
Q1 		$387K Hold
16,021
– – ﹤0.01% 2050
2021
Q4 		$381K Buy
16,021
+321
+2% +$7.47K ﹤0.01% 2170
2021
Q3 		$398K Hold
15,700
– – ﹤0.01% 2187
2021
Q2 		$353K Buy
15,700
+3,474
+28% +$71.1K ﹤0.01% 2296
2021
Q1 		$241K Buy
12,226
+4,528
+59% +$114K ﹤0.01% 2436
2020
Q4 		$205K Buy
7,698
+1,845
+32% +$68.6K ﹤0.01% 2408
2020
Q3 		$289K Sell
5,853
-200,469
-97% -$7.98M ﹤0.01% 1970
2020
Q2 		$6.52M Buy
+206,322
New +$6.64M 0.02% 663

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

VOYA Investment Management's PCVX Position: Q2 2026 in Review

VOYA Investment Management increased its Vaxcyte (PCVX) stake by 5.8% in Q2 2026, buying an estimated $193K and bringing the position to 65,110 shares worth $3.78M. The position accounts for ﹤0.01% of the portfolio, ranked #982.

VOYA Investment Management first reported a position in PCVX in Q2 2020 and has held it in 25 quarters since. The position peaked at $34.7M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • VOYA Investment Management held 65,110 shares of Vaxcyte worth $3.78M as of Q2 2026.
  • VOYA Investment Management bought 3,547 Vaxcyte shares in Q2 2026, an estimated $193K.
  • Vaxcyte made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #982 holding.
  • VOYA Investment Management first reported a position in Vaxcyte in Q2 2020 and has held it in 25 quarters since.
  • VOYA Investment Management's Vaxcyte position peaked at $34.7M in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.